Jyothy Labs Limited announced its financial results for the quarter and half-year ended September 30, 2026. The company reported revenue growth driven by its core brands, despite challenging market conditions. Management discussed strategies to improve profitability, including calibrated pricing, cost efficiencies, and product mix enhancements. The outlook highlights a focus on sustained growth in key segments and managing input cost inflation.
Jyothy Labs Announces Q2 and H1 FY27 Results
Jyothy Labs Limited has released its financial results for the second quarter and the first half of the financial year 2027, ending September 30, 2026. The company reported revenue from operations of INR760 crores for Q2 FY27, a 3.3% increase compared to the previous year. Excluding the impact of the exit from the Pril and Fa businesses, the underlying business showed a healthy 12.4% value growth and 8.1% volume growth.
Performance and Market Environment
During the quarter, the FMCG sector faced a challenging operating environment due to geopolitical uncertainty and elevated commodity prices. These factors, particularly increases in crude derivatives and packaging costs, significantly impacted gross margins, which compressed to 34.8% from 48.1% in the previous year. The company implemented price increases of approximately 4% across its portfolio to partially offset these costs.
Segment Highlights and Strategy
Fabric Care emerged as a key growth driver, delivering 10.4% value growth, with liquid detergents showing over 50% year-on-year growth. The Home Care segment, excluding Pril, grew by 15.3%, largely driven by volumes, with Exo dishwash performing strongly with a 23% growth. Personal Care saw over 11% value growth, supported by pricing actions for Margo.
Management emphasized a focus on strengthening the Margo franchise and progressively restoring category margins. Priorities include sustained growth in Fabric Care, improving Home Invest profitability, and scaling newer formats. The company also announced a share buyback of INR147 crores at INR215 per share, reflecting confidence in its long-term fundamentals.
Financial Outlook and Capital Allocation
For the first half of FY27, revenue from operations stood at INR1,533 crores. The company’s balance sheet remains strong with approximately INR846 crores in cash and no debt. Looking ahead, Jyothy Labs aims to deliver double-digit growth in FY27, with margin recovery expected to be progressive, dependent on commodity price stabilization. The company continues to evaluate acquisition opportunities and maintain its dividend payout policy.
Source: BSE
